// App-Quantinova.ai

TP0803 : Efficacy of mepolizumab in severe eosinophilic asthma by baseline eosinophil count and exacerbation history: Meta‐analysis of two phase 3 trials

Researchers

Presenter

  • Albers F

Principal Investigators

  • Howarth P

  • Bratton D

  • Yancey S

  • Bradford E

  • Kwon N

Medical Centers

  • US EPA, Research Triangle Park, NC, United States,

  • University of Southampton, Southampten, United Kingdom

  • GSK, Brentford, United Kingdom

  • GSK, Uxbridge, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Recepteur d'Origine Nantais

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved